Pfizer Launches Champix In China
This article was originally published in PharmAsia News
Executive Summary
Pfizer launched its prescriptive medicine for smokers in China. Champix (varenicline) received approval as a prescription drug to stop smoking from China's State FDA in July. According to the latest epidemiology survey, the number of smokers in China exceeds 350 million, putting it highest worldwide in terms of absolute figure. About one million Chinese die of smoking-related diseases each year. Medical experts say that with the aid of a drug treatment under the supervision of doctors, the success rate of quitting smoking can be doubled. Champix has been in the U.S. market since 2006 and is recommended as a first-line drug. (Click here for more - Chinese language)